HK1004326A1 - Novel uses of il-10 - Google Patents

Novel uses of il-10

Info

Publication number
HK1004326A1
HK1004326A1 HK98103387A HK98103387A HK1004326A1 HK 1004326 A1 HK1004326 A1 HK 1004326A1 HK 98103387 A HK98103387 A HK 98103387A HK 98103387 A HK98103387 A HK 98103387A HK 1004326 A1 HK1004326 A1 HK 1004326A1
Authority
HK
Hong Kong
Prior art keywords
novel uses
alone
optionally
manufacture
combination
Prior art date
Application number
HK98103387A
Other languages
English (en)
Inventor
Robert Coffman
Jane E De Vries
Rene De Waal Malefyt
Fiona Powrie
Donna Rennick
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/932,900 external-priority patent/US5368854A/en
Application filed by Schering Corp filed Critical Schering Corp
Publication of HK1004326A1 publication Critical patent/HK1004326A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/247—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/74—Inducing cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
HK98103387A 1992-08-20 1998-04-23 Novel uses of il-10 HK1004326A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US07/932,900 US5368854A (en) 1992-08-20 1992-08-20 Use of IL-10 to treat inflammatory bowel disease
US93346292A 1992-08-21 1992-08-21
US93395092A 1992-08-21 1992-08-21
US93341992A 1992-08-21 1992-08-21
PCT/US1993/007646 WO1994004180A2 (en) 1992-08-20 1993-08-18 Novel uses of il-4 and/or il-10, and antibodies against the same

Publications (1)

Publication Number Publication Date
HK1004326A1 true HK1004326A1 (en) 1998-11-20

Family

ID=27506019

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98103387A HK1004326A1 (en) 1992-08-20 1998-04-23 Novel uses of il-10

Country Status (23)

Country Link
EP (2) EP0801951A3 (ja)
JP (1) JP3494647B2 (ja)
KR (1) KR0170037B1 (ja)
CN (1) CN1090204A (ja)
AT (1) ATE162947T1 (ja)
AU (1) AU680628B2 (ja)
CA (1) CA2142861C (ja)
CZ (1) CZ283488B6 (ja)
DE (1) DE69316921T2 (ja)
DK (1) DK0671933T3 (ja)
ES (1) ES2111769T3 (ja)
FI (1) FI950697A (ja)
GR (1) GR3026635T3 (ja)
HK (1) HK1004326A1 (ja)
HU (1) HU220103B (ja)
IL (1) IL106725A (ja)
MX (1) MX9305054A (ja)
MY (1) MY111402A (ja)
PL (1) PL307566A1 (ja)
RU (1) RU2120802C1 (ja)
SK (1) SK21195A3 (ja)
TW (1) TW243415B (ja)
WO (1) WO1994004180A2 (ja)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2155109A1 (en) * 1993-02-01 1994-08-18 Daniel Abramowicz Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10
CN1216992C (zh) 1994-07-05 2005-08-31 史廷诺研究集团有限公司 免疫调节剂
US6410008B1 (en) 1994-12-12 2002-06-25 Beth Israel Hospital Association Chimeric IL-10 proteins and uses thereof
WO1996018412A1 (en) * 1994-12-12 1996-06-20 Beth Israel Hospital Association Chimeric cytokines and uses thereof
US5770190A (en) * 1995-07-14 1998-06-23 Schering Corporation Method of treatment of acute leukemia with inteleukin-10
EP0756871A1 (en) * 1995-08-01 1997-02-05 Institut Pasteur Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10
AU734807B2 (en) * 1996-04-17 2001-06-21 Patrick T. Prendergast Dhea combination therapy
WO1998027997A1 (en) * 1996-12-20 1998-07-02 Magainin Pharmaceuticals Inc. A method for diagnosis and treatment of inflammatory bowel diseases including crohn's disease and chronic ulcerative colitis
AU5221998A (en) * 1997-04-17 1998-11-13 Patrick T. Prendergast Combination therapy utilising 17-ketosteroids and interleukin inhibitors, or interleukin-10 potionally with interleukin inhibitors
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US6001651A (en) * 1998-03-20 1999-12-14 Isis Pharmaceuticals Inc. Antisense modulation of LFA-3
CA2343840C (en) * 1998-10-20 2011-03-08 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Use of a cytokine-producing lactococcus strain to treat colitis
NZ514095A (en) 1999-02-10 2001-09-28 Welfide Corp Amide compounds and medicinal use thereof
DK2295968T3 (da) * 1999-12-03 2012-12-17 Baxter Healthcare Sa Pyrogenicitetsprøve til anvendelse i forbindelse med automatiserede immunanalysesystemer
CN1981868A (zh) * 2000-03-31 2007-06-20 拜奥根Idec公司 抗细胞因子抗体或拮抗剂与抗－cd20在b细胞淋巴瘤治疗中的联合应用
CN1441675A (zh) 2000-05-12 2003-09-10 贝斯以色列护理医疗中心有限公司 免疫抑制组合物及方法
US20040197304A1 (en) 2003-04-01 2004-10-07 The Procter & Gamble Company And Alimentary Health, Ltd. Methods of determining efficacy of treatments of inflammatory diseases of the bowel
US7261882B2 (en) * 2003-06-23 2007-08-28 Reagents Of The University Of Colorado Methods for treating neuropathic pain by administering IL-10 polypeptides
WO2005047324A2 (en) 2003-11-10 2005-05-26 Schering Corp ANTI-INTERLEUKIN ANTIBODY-10
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
AR050044A1 (es) 2004-08-03 2006-09-20 Novartis Ag Anticuerpo especifico de il-4
AR052472A1 (es) 2005-05-31 2007-03-21 Iams Company Lactobacilos probioticos para felinos
CA2607949C (en) 2005-05-31 2012-09-25 Thomas William-Maxwell Boileau Feline probiotic bifidobacteria
US20080254014A1 (en) * 2005-10-03 2008-10-16 Actogenix N V Use of Recombinant Yeast Strain Producing an Anti-Inflammatory Compound to Treat Colitis
CA2664304C (en) * 2006-09-28 2017-08-22 Schering Corporation Use of pegylated il-10 to treat cancer
AU2008211600B8 (en) 2007-02-01 2014-02-13 Mars, Incorporated Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
CN105209054A (zh) * 2013-04-18 2015-12-30 阿尔莫生物科技股份有限公司 使用白细胞介素-10治疗疾病和病症的方法
ES2688206T3 (es) 2013-06-17 2018-10-31 Armo Biosciences, Inc. Procedimiento de evaluación de la identidad y la estabilidad de proteínas
RS59735B1 (sr) 2013-07-18 2020-02-28 Xalud Therapeutics Inc Sastav za tretman upalnih bolesti zglobova
CN105658232A (zh) 2013-08-30 2016-06-08 阿尔莫生物科技股份有限公司 使用白细胞介素-10治疗疾病和病症的方法
CN108025040A (zh) 2015-08-25 2018-05-11 阿尔莫生物科技股份有限公司 使用白介素-10治疗疾病和病症的方法
CN114349858B (zh) * 2022-01-26 2022-07-01 优睿赛思(武汉)生物科技有限公司 抗人白介素-10高亲和力兔单克隆抗体及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
SK279556B6 (sk) * 1991-01-16 1998-12-02 Schering Corporation Liečivo na liečenie nádorov pacienta
GB9207732D0 (en) * 1992-04-06 1992-05-27 Isis Innovation Wound repair

Also Published As

Publication number Publication date
RU95108330A (ru) 1996-11-27
PL307566A1 (en) 1995-05-29
DE69316921D1 (de) 1998-03-12
HU9500467D0 (en) 1995-04-28
MY111402A (en) 2000-04-29
WO1994004180A2 (en) 1994-03-03
CZ283488B6 (cs) 1998-04-15
WO1994004180A3 (en) 1994-06-09
KR950702841A (ko) 1995-08-23
SK21195A3 (en) 1996-10-02
TW243415B (ja) 1995-03-21
RU2120802C1 (ru) 1998-10-27
FI950697A0 (fi) 1995-02-16
HU220103B (hu) 2001-10-28
HUT70976A (en) 1995-11-28
DK0671933T3 (da) 1998-09-23
EP0801951A2 (en) 1997-10-22
JPH08500362A (ja) 1996-01-16
CA2142861A1 (en) 1994-03-03
JP3494647B2 (ja) 2004-02-09
ATE162947T1 (de) 1998-02-15
KR0170037B1 (ko) 1999-02-01
CA2142861C (en) 2000-08-15
AU680628B2 (en) 1997-08-07
EP0671933B1 (en) 1998-02-04
IL106725A0 (en) 1993-12-08
CZ44195A3 (en) 1995-10-18
FI950697A (fi) 1995-04-07
DE69316921T2 (de) 1998-06-04
AU5010893A (en) 1994-03-15
GR3026635T3 (en) 1998-07-31
IL106725A (en) 2000-12-06
EP0801951A3 (en) 1998-05-20
MX9305054A (es) 1994-02-28
CN1090204A (zh) 1994-08-03
EP0671933A1 (en) 1995-09-20
ES2111769T3 (es) 1998-03-16

Similar Documents

Publication Publication Date Title
TW243415B (ja)
IL128425A0 (en) Taxane derivatives their preparation and pharmaceutical compositions containing them
DE3865817D1 (ja)
IL115790A0 (en) Pharmaceutical compositions containing boronic ester and acid compounds and methods for the preparation thereof
EP0590969A3 (en) Low gloss polycarbonate and ABS molding compositions.
EP0602861A3 (en) Mixed condensation product and rubber mixture containing it.
PH31297A (en) Antiperspirant aerosol composition with high solids content.
IL110249A0 (en) Iodinated oligomeric compounds and diagnostic compositions containing the same
BG103968A (en) Pharmaceutical antiviral composition containing glycirricinic acid and at least one protein with antiviral activity
EP0317602A1 (en) ANTI-OXIDIZING PRODUCTS.
ES2037073T3 (es) Un producto para el cuidado de la boca.
EP0638080A4 (en) PYRIMIDINE 7-BISUBSTITUEE-METHYL-4-OXO-3H -, 5H --PYRROLO 3,2-d -], PHARMACEUTICAL USE AND COMPOSITIONS CONTAINING SAID PYRIMIDINE.
GR3024028T3 (en) Cytotoxic and antiviral compound.
ZA953700B (en) Novel sulfenamide accelerators and rubber compositions containing the same
EP0461261A4 (en) MIXTURE OF OLIGOPEPTIDES AND PREPARATION CONTAINING SAME.
NZ218701A (en) Stabilized hydrogen peroxide composition and uses for the antimicrobial effects thereof
TW218011B (ja)
IL105285A0 (en) Compositions for the treatment of diabetes
GR3022709T3 (en) Aerosol composition containing fusafungine.
NZ314940A (en) Synergistic pharmaceutical compositions containing the cytokines il-4 and il-10 for use in inhibiting delayed-type hypersensitivity reaction
HU905996D0 (en) Tetrahydron built from the groups of 2, 4 or 6 pieces of balls
IL81628A0 (en) 1,3-diketone derivatives and pharmaceutical compositions containing the same
IL119421A0 (en) Pharmaceutical compositions for the treatment of arrhythmia

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20050818